Smart drug that strips cancer cells of ‘invisibility cloak’ can shrink tumours by 30%, trial shows
A new experimental drug, GRWD5769, has shown success in clinical trials by helping immunotherapy treatments identify and shrink tumors. The drug works by removing the 'invisibility cloak' that cancer cells use to hide from the immune system.
Why it matters
This represents a significant medical breakthrough that could improve survival rates for patients with common, hard-to-treat cancers.
Immunotherapy struggles when tumours hide from the immune system. GRWD5769 solves this problem by making cancer cells (pink) visible to T-cells (white). Illustration: Nemes Laszlo/Alamy View image in fullscreen Immunotherapy struggles when tumours hide from the immune system. GRWD5769 solves this problem by making cancer cells (pink) visible to T-cells (white). Illustration: Nemes Laszlo/Alamy Cancer Smart drug that strips cancer cells of ‘invisibility cloak’ can shrink tumours by 30%, trial shows Experimental tablet produces encouraging results in patients with world’s most common forms of disease
The article reports on scientific trial results using objective data and expert findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in